DANAHER CORPORATION Funds and ETFs Danaher Corporation
Equities
DHR
US2358511028
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.2 USD | +0.29% |
|
+5.28% | +14.42% |
ETFs positioned on Danaher Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.11% | 6 M€ | +3.89% | ||
| 0.11% | 17 M€ | +3.30% | - | |
| 0.08% | 7 M€ | +6.84% | - | |
| 0.08% | 32 M€ | +2.15% | - | |
| 0.08% | 17 M€ | +6.84% | - | |
| 0.07% | 2 M€ | +3.16% | - | |
| 0.07% | 756 M€ | +1.21% | - | |
| 0.06% | 6 M€ | -4.26% | - | |
| 0.06% | 54 M€ | +1.52% | - | |
| 0.05% | 8 M€ | +1.26% | - | |
| 0.05% | 15 M€ | -1.62% | - | |
| 0.03% | 34 M€ | +4.39% | - | |
| 16.74% | 129 M€ | +8.42% | - |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
18/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
263.5
USD
Average target price
272.7
USD
Spread / Average Target
+3.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.42% | 20TCr | |
| +12.80% | 23TCr | |
| +17.95% | 14TCr | |
| +29.18% | 11TCr | |
| +3.27% | 6.49TCr | |
| +18.57% | 5.43TCr | |
| +7.63% | 5.21TCr | |
| +11.07% | 4.52TCr | |
| +5.72% | 3.74TCr | |
| +28.39% | 3.24TCr |
- Stock Market
- Equities
- DHR Stock
- Funds and ETFs Danaher Corporation
